Recurrence of Punctate Inner Choroidopathy with an Intravitreal Dexamethasone Implant. |
Min Ho Shin, Hyun Ji Kang, In Young Chung |
1Department of Ophthalmology, Gyeongsang National University School of Medicine, Jinju, Korea. in0chung@hanmail.net 2Gyeongsang Institute of Health Science, Gyeongsang National University, Jinju, Korea. |
덱사메타손 임플란트 주입술 치료 후 재발된 점상내측맥락막병증 1예 |
신민호1⋅강현지1⋅정인영1,2 |
경상대학교 의학전문대학원 안과학교실1, 경상대학교 건강과학연구원2 |
Correspondence:
In Young Chung, Email: in0chung@hanmail.net |
Received: 10 August 2017 • Revised: 19 September 2017 • Accepted: 26 October 2017 |
Abstract |
PURPOSE To report a case of punctate inner choroidopathy (PIC) treated with an intravitreal dexamethasone implant due to side effects of systemic steroid treatment. CASE SUMMARY: A 23-year-old highly myopic female who presented with PIC in her right eye was treated with an intravitreal dexamethasone implant due to side effects of systemic steroid treatment including facial edema and sleep disturbances. Three months after the implant she complained of severe acute visual disturbances in her right eye. Her visual acuity was classified as hand movement. Choroidal neovascularization (CNV) was observed on optical coherence tomography and indocyanine green angiography revealed more multiple hypofluorescent lesions compared to the initial visit. Six months after the systemic steroid and intravitreal bevacizumab injection treatments, visual acuity in right eye improved and the CNV disappeared. CONCLUSIONS: This report describes a case of PIC after, treatment with an intravitreal dexamethasone implant due to the side effects of systemic steroid treatment, which recurred with complications. |
Key Words:
Intravitreal bevacizumab;Intravitreal dexamethasone implant;Punctate inner choroidopathy;Systemic steroid |